This poster highlights a scoping literature review which aimed to synthesize the current evidence on burden of BKV infection and BKVN in kidney transplant recipients, with a focus on identifying patient-centered research and outcomes.

Memo Therapeutics AG has been acquired by Ipsen

Ipsen